CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $16,722,000 | -55.6% | 600,000 | -70.9% | 0.14% | -60.3% |
| Q4 2014 | $37,635,000 | +33.1% | 2,062,200 | -5.5% | 0.36% | +22.0% |
| Q3 2014 | $28,274,000 | -20.6% | 2,181,600 | 0.0% | 0.30% | -29.4% |
| Q2 2014 | $35,604,000 | -14.2% | 2,181,600 | -7.1% | 0.42% | -18.0% |
| Q1 2014 | $41,482,000 | +30.7% | 2,347,600 | +79.1% | 0.51% | +9.4% |
| Q4 2013 | $31,730,000 | – | 1,310,600 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |